Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies (C


Journal

Monoclonal antibodies in immunodiagnosis and immunotherapy
ISSN: 2167-9436
Titre abrégé: Monoclon Antib Immunodiagn Immunother
Pays: United States
ID NLM: 101590955

Informations de publication

Date de publication:
Apr 2023
Historique:
medline: 3 5 2023
pubmed: 19 4 2023
entrez: 19 04 2023
Statut: ppublish

Résumé

One of G protein-coupled receptors, CC chemokine receptor 3 (CCR3), is expressed in eosinophils, basophils, a subset of Th2 lymphocytes, mast cells, and airway epithelial cells. CCR3 levels in the serum of colorectal cancer patients are significantly higher than in control groups. Moreover, CCR3 is essential for recruiting eosinophils into the lung. Therefore, CCR3 is considered both a therapeutic target for colorectal cancer and allergic diseases. Previously, we established anti-mouse CCR3 (mCCR3) monoclonal antibodies (mAbs), C

Identifiants

pubmed: 37074100
doi: 10.1089/mab.2022.0034
doi:

Substances chimiques

Receptors, CCR3 0
Antibodies, Monoclonal 0
Immunoglobulin G 0
Ccr3 protein, rat 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

68-72

Auteurs

Nami Tateyama (N)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.

Teizo Asano (T)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.

Tomohiro Tanaka (T)

Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan.

Yu Isoda (Y)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.

Yuki Okada (Y)

Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan.

Hiyori Kobayashi (H)

Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan.

Guanjie Li (G)

Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan.

Ren Nanamiya (R)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.

Takeo Yoshikawa (T)

Department of Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Mika K Kaneko (MK)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan.

Hiroyuki Suzuki (H)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan.

Yukinari Kato (Y)

Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Molecular Pharmacology, and Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH